Also, both single and double knockdown of HSPA1 and/or HSPA2 genes did not increase sensitivity of NSCLC cells to the drugs (Figs 2G–K, 3E,F and S1G–K). This evidence concerns the gene HSPA2 and non-small cell lung carcinoma.